Target intelligence / Profile preview

Neuronal nicotinic acetylcholine receptor subunit alpha-2-beta-2 (α2β2 nAChR)

Target
α2β2 nAChR
Molecular classification
Ligand-gated ion channel, Cys-loop receptor superfamily, Pentameric receptor, Cation channel, Nicotinic acetylcholine receptor
01

Overview

The neuronal nicotinic acetylcholine receptor α2β2 is a heteromeric, pentameric ligand-gated ion channel belonging to the Cys-loop superfamily. This receptor is composed of five subunits arranged around a central water-filled pore, specifically containing alpha-2 (CHRNA2) and beta-2 (CHRNB2) subunits[1][2]. The α2β2 nAChR forms a functional heteropentameric receptor complex with high calcium permeability among other cations[5][8]. Structurally, each subunit contains four transmembrane segments (M1-M4), with a large extracellular N-terminal domain and a small C-terminal region[1][2]. The ligand-binding sites are located at the interfaces between the α and β subunits in the extracellular N-terminal domain. The second transmembrane segment (M2) from each subunit primarily forms the wall of the ionic pore, which is mainly permeable to sodium and calcium ions[2]. The α2 subunit contains characteristic adjacent cysteine residues (Cys192 and Cys193) in the extracellular domain that define it as an alpha subunit[1][2]. The receptor functions as a pentameric complex that can be activated by endogenous acetylcholine or exogenous ligands like nicotine, opening the cation channel upon ligand binding[2]. The α2β2 nAChR plays important roles in modulating neurotransmitter release, cell excitability, neuronal integration, and networking throughout the central nervous system[6]. These receptors are involved in various physiological functions and are considered important therapeutic targets[4]. The β2 subunit is an indispensable component for many nAChR-mediated functions and contributes significantly to the physiological and pharmacological properties of the receptor, including desensitization, inward rectification, and functional characteristics[2]. The receptor exhibits typical nAChR conformational states including closed (resting), open (activated), and desensitized states[1]. The kinetics of these transitions, ionic conductance, and pharmacological properties depend on the specific subunit composition. The α2β2 subtype represents one of the many possible heteromeric combinations that contribute to the functional diversity of neuronal nicotinic receptors in the mammalian brain[1].

Other names
α2β2 nicotinic receptoralpha-2-beta-2 nAChRCHRNA2-CHRNB2 receptor complexNeuronal acetylcholine receptor α2β2 subtype
02

Mechanism of action

Ligand-gated ion channel activation; Cation influx (primarily sodium and calcium); Membrane depolarization; Downstream calcium signaling cascades; Modulation of neuronal excitability

03

Biological functions

Neurotransmitter signalingSignal transductionNeuronal excitability regulationSynaptic transmissionCalcium permeability and signalingNeurotransmitter release modulationNeuronal integration and networking
04

Disease associations

Nicotine dependence and addictionNeurological disordersCognitive dysfunctionPotential involvement in neurodegenerative conditions
05

Safety considerations

Potential for receptor desensitization with chronic agonist exposureCalcium permeability may contribute to excitotoxicity under certain conditionsRole in nicotine addiction pathways
06

Interacting drugs

Nicotine

2 more in the full profile.

Beyond the preview

Go deeper on Neuronal nicotinic acetylcholine receptor subunit alpha-2-beta-2 (α2β2 nAChR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuronal nicotinic acetylcholine receptor subunit alpha-2-beta-2 (α2β2 nAChR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call